0001209191-17-003002.txt : 20170109 0001209191-17-003002.hdr.sgml : 20170109 20170109173411 ACCESSION NUMBER: 0001209191-17-003002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170105 FILED AS OF DATE: 20170109 DATE AS OF CHANGE: 20170109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vanover Kimberly E. CENTRAL INDEX KEY: 0001585669 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 17518716 MAIL ADDRESS: STREET 1: C/O INTRA-CELLULAR THERAPIES, INC. STREET 2: 3960 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10032 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-05 0 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001585669 Vanover Kimberly E. C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016 0 1 0 0 SVP, Clinical Development Common Stock 2017-01-05 4 S 0 800 16.59 D 10128 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016. The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.33 to $16.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. /s/ Lawrence J. Hineline, Attorney-in-fact 2017-01-09